EXSCEL Trademark

Trademark Overview

On Thursday, June 3, 2010, a trademark application was filed for EXSCEL with the United States Patent and Trademark Office. The USPTO has given the EXSCEL trademark a serial number of 85053872. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, January 28, 2022. This trademark is owned by Amylin Pharmaceuticals, Inc.. The EXSCEL trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and scientific research, namely, conducting clinical trials for pharmaceutical preparations for the treatment of type 2 diabetes and their impact on cardiovascular disease
exscel

General Information

Serial Number85053872
Word MarkEXSCEL
Filing DateThursday, June 3, 2010
Status710 - CANCELLED - SECTION 8
Status DateFriday, January 28, 2022
Registration Number4003668
Registration DateTuesday, July 26, 2011
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, October 26, 2010

Trademark Statements

Description of MarkThe mark consists of the word "EXSCEL" in all capital letters. To the right of the word "EXSCEL" is a design image of a twisting band.
Pseudo MarkEXENATIDE STUDY OF CARDIOVASCULAR EVENT LOWERING; EXCEL
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesMedical and scientific research, namely, conducting clinical trials for pharmaceutical preparations for the treatment of type 2 diabetes and their impact on cardiovascular disease

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, January 28, 2022
Primary Code042
First Use Anywhere DateFriday, June 18, 2010
First Use In Commerce DateFriday, June 18, 2010

Trademark Owner History

Party NameAMYLIN PHARMACEUTICALS, LLC
Party Type31 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressSödertälje SE-15185
SE
Party NameAmylin Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameAmylin Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameAmylin Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events

Event DateEvent Description
Friday, January 28, 2022CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Thursday, July 22, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, July 22, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 22, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 22, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, July 22, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sunday, July 26, 2020COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Tuesday, May 16, 2017NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Tuesday, May 16, 2017REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, May 16, 2017CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, April 4, 2017TEAS SECTION 8 & 15 RECEIVED
Tuesday, July 26, 2016COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, March 24, 2014ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 24, 2014TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, May 29, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, May 29, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, October 31, 2012AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, July 26, 2011REGISTERED-PRINCIPAL REGISTER
Tuesday, June 21, 2011NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, June 20, 2011LAW OFFICE REGISTRATION REVIEW COMPLETED
Thursday, June 16, 2011ASSIGNED TO LIE
Thursday, June 9, 2011ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, May 20, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 19, 2011STATEMENT OF USE PROCESSING COMPLETE
Tuesday, May 17, 2011USE AMENDMENT FILED
Thursday, May 19, 2011EXTENSION 1 GRANTED
Tuesday, May 17, 2011EXTENSION 1 FILED
Thursday, May 19, 2011CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, May 17, 2011TEAS EXTENSION RECEIVED
Tuesday, May 17, 2011TEAS STATEMENT OF USE RECEIVED
Tuesday, December 21, 2010NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 26, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 26, 2010PUBLISHED FOR OPPOSITION
Tuesday, September 21, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, September 21, 2010ASSIGNED TO LIE
Monday, September 13, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, September 10, 2010ASSIGNED TO EXAMINER
Thursday, June 10, 2010NOTICE OF DESIGN SEARCH CODE MAILED
Wednesday, June 9, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, June 7, 2010NEW APPLICATION ENTERED IN TRAM

Related Keywords

exscel diabetes type treatment their impact disease cardiovascular preparations pharmaceutical research